Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Chemokine receptor CXCR7 antagonism ameliorates cardiac and renal fibrosis induced by mineralocorticoid excess ; volume:14 ; number:1 ; day:6 ; month:11 ; year:2024 ; pages:1-13 ; date:12.2024
Scientific reports ; 14, Heft 1 (6.11.2024), 1-13, 12.2024
- Creator
-
Wang, Bing H.
Robert, Remy
Marques, Francine Z.
Rajapakse, Niwanthi
Kiriazis, Helen
Mackay, Charles R.
Kaye, David M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-75789-0
- URN
-
urn:nbn:de:101:1-2501242107349.283641649440
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Bing H.
- Robert, Remy
- Marques, Francine Z.
- Rajapakse, Niwanthi
- Kiriazis, Helen
- Mackay, Charles R.
- Kaye, David M.
- SpringerLink (Online service)
Other Objects (12)
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivoaxial diffusivity
Atypical chemokine receptor 3 (ACKR3/CXCR7) modulates thrombotic and thrombo-inflammatory platelet functions
The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivoaxial diffusivity
Atypical chemokine receptor 3 (ACKR3/CXCR7) modulates thrombotic and thrombo-inflammatory platelet functions
The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells
Mineralocorticoid receptor antagonism limits experimental choroidal neovascularization and structural changes associated with neovascular age-related macular degeneration
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage
Mineralocorticoid-receptor antagonism and its metabolic consequences in haemodialysis patients
Apparent mineralocorticoid excess: comprehensive overview of molecular genetics
The novel chemokine receptor CXCR7 regulates trans-endothelial migration of cancer cells
Sex-specific responses to mineralocorticoid receptor antagonism in hypertensive African American males and females
CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivoaxial diffusivity
Atypical chemokine receptor 3 (ACKR3/CXCR7) modulates thrombotic and thrombo-inflammatory platelet functions
The chemokine receptor CXCR7 interacts with EGFR to promote breast cancer cell proliferation
Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells
Impact of the Chemokine Receptors CXCR4 and CXCR7 on Clinical Outcome in Adrenocortical Carcinoma
Chemokine receptor CXCR7 regulates the invasion, angiogenesis and tumor growth of human hepatocellular carcinoma cells